×

Stocks Eli Lilly and Co

  • graphic_word_ofthe_street.jpg

    The Dow fell by triple digits on Tuesday as worries about further losses stemming from the mortgage crisis moved back into the spotlight.

  • graphic_fast_money.jpg

    The boss at Eli Lilly offers his diagnosis on Big Pharma's prospects.

  • Cramer offers up five reasons why this sector is the best one to own through the fall. Plus, the top stocks in the group.

  • Elan

    The Elanians have been pretty quiet in the wake of last week's bad news. and the stock getting about a two-thirds haircut. And I don't mean to rub salt in the wound.

  • Lilly

    In the latest move in the big pharma restructuring/outsourcing trend, Eli Lilly announced this morning that it's selling a lab site in its home state of Indiana to the contract research organization Covance.

  • What a crazy week, right? Monday, Amgen had a huge upside revenue and earnings surprise. Tuesday, the Food and Drug Administration issued its new restrictions on the use of Amgen's anemia drugs in certain cancer patients. Later that same day, Elan and Wyeth released the big Alzheimer's drug test results.

  • Stocks ended sharply lower Thursday as the market got a triple whammy: Oil resumed its ascent, major earnings reports sparked a fresh wave of concern about corporate profits and home sales hit a 10-year low. All three major indexes lost at least  2 percent.

  • Stocks declined as oil resumed its ascent and investors braced for the next batch of corporate earnings.  A drop in home sales and a jump in jobless claims above the key 400,000 mark added some pressure.

  • Stocks declined as oil resumed its ascent and investors braced for the next batch of corporate earnings.  A drop in home sales and a jump in jobless claims above the key 400,000 mark added some pressure.

  • On Squawk Box this morning, CEOs from various industries aired their insights on the economy, energy prices, real estate and politics.

  • cialis_package.jpg

    So, yesterday I posited a theory that the weak American economy might be hurting sales growth of erectile dysfunction drugs. I wondered whether men might be cutting their pills in half and/or not filling their expensive prescriptions if they're having to tighten their belts.

  • Stocks declined as oil resumed its ascent and investors braced for the next batch of corporate earnings.  A drop in home sales and a jump in jobless claims above the key 400,000 mark added some pressure.

  • Bristol-Myers Squibb on Thursday posted quarterly earnings that beat forecasts, helped by higher sales of blood clot preventer Plavix and schizophrenia treatment Abilify, and the company announced an additional $1 billion in planned cost cuts.

  • eli_lilly_earnings.jpg

    Eli Lilly said on Thursday that second-quarter earnings rose on higher sales of its prescription drugs and sharply lower taxes, but the company cut its 2008 profit forecast due to special charges.

  • Oil's move to a six-week low has been cheering the stock market, but the question is for how long?

  • FFF_Fast_Furious_Thumb.jpg

    Following are the “Fast & Furious” trades - hot ways to play tomorrow's market moving events.

  • On the Pfizer earnings conference call this morning Chairman and CEO Jeff Kindler kicked things off by calling this a "time of great uncertainty in the world economy and capital markets and significant challenges in our industry."

  • pfizer_hq.jpg

    Pfizer Wednesday said quarterly earnings more than doubled on higher sales of its prescription drugs and lower expenses, but its Chantix quit-smoking drug lost more than a third of its U.S. sales amid safety concerns.

  • Lilly

    More than ten years after Pfizer brought Viagra to market and brought erectile dysfunction out of the closet a new survey says a lot of men are still too embarrassed to talk about impotence with their doctor.

  • Pharma Stocks

    One day does not a full-fledged sector rotation make, but yesterday the big pharma stocks put on a show and in the early going today the curtain hasn't fallen. Pfizer even broke above 18 bucks!